| scholarly article | Q13442814 |
| P356 | DOI | 10.1023/A:1008290406221 |
| P698 | PubMed publication ID | 9496387 |
| P2093 | author name string | A Harstrick | |
| Y M Rustum | |||
| S Cao | |||
| S Seeber | |||
| U Vanhoefer | |||
| P2860 | cites work | Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line | Q24338329 |
| Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
| New colorimetric cytotoxicity assay for anticancer-drug screening | Q29615418 | ||
| The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump | Q35749376 | ||
| Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. | Q36019240 | ||
| Taxol-requiring mutant of Chinese hamster ovary cells with impaired mitotic spindle assembly | Q36207520 | ||
| The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer | Q36430961 | ||
| Effect of calcium antagonists on the chemosensitivity of two multidrug-resistant human tumour cell lines which do not overexpress P-glycoprotein | Q36466963 | ||
| Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer | Q40397088 | ||
| Docetaxel | Q40434995 | ||
| Docetaxel: an active new drug for treatment of advanced epithelial ovarian cancer | Q40684894 | ||
| Dose-intense taxol: high response rate in patients with platinum-resistant recurrent ovarian cancer | Q40705982 | ||
| Promising new agents in the treatment of non-small cell lung cancer | Q40969505 | ||
| Carbamoylation of glutathione reductase by N,N-bis(2-chloroethyl)-N- nitrosourea associated with inhibition of multidrug resistance protein (MRP) function | Q41120241 | ||
| DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux | Q41171041 | ||
| Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein | Q41331081 | ||
| Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance. | Q41523907 | ||
| Effects of Taxotere on murine and human tumor cell lines | Q41607418 | ||
| Assembly of purified GDP-tubulin into microtubules induced by taxol and taxotere: reversibility, ligand stoichiometry, and competition | Q48318693 | ||
| Taxol: mechanisms of action and resistance | Q48421472 | ||
| Relationships between the structure of taxol analogs and their antimitotic activity | Q48789967 | ||
| Chemosensitisation and drug accumulation effects of cyclosporin A, PSC-833 and verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from P-glycoprotein. | Q54252365 | ||
| Taxol resistant mutants of Chinese hamster ovary cells: genetic biochemical, and cross-resistance studies. | Q54508306 | ||
| Comparison of paclitaxel and docetaxel activity on human ovarian carcinoma xenografts | Q60043772 | ||
| Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of Taxol | Q64884897 | ||
| Expression of the multidrug-resistance-associated protein (MRP) gene in human colorectal, gastric and non-small-cell lung carcinomas | Q71007123 | ||
| Phase I crossover study of paclitaxel with r-verapamil in patients with metastatic breast cancer | Q71121095 | ||
| Restoration of taxol sensitivity of multidrug-resistant cells by the cyclosporine SDZ PSC 833 and the cyclopeptolide SDZ 280-446 | Q72212408 | ||
| Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublines in vitro | Q72645064 | ||
| Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancer | Q73177841 | ||
| P433 | issue | 12 | |
| P921 | main subject | multiple drug resistance | Q643839 |
| docetaxel | Q420436 | ||
| paclitaxel | Q423762 | ||
| tumour xenograft | Q112042499 | ||
| P304 | page(s) | 1221-1228 | |
| P577 | publication date | 1997-12-01 | |
| P1433 | published in | Annals of Oncology | Q326122 |
| P1476 | title | Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that overexpress the multidrug resistance protein (MRP) | |
| P478 | volume | 8 |
| Q44315213 | A phase II study of docetaxel in paclitaxel-resistant ovarian and peritoneal carcinoma: a Gynecologic Oncology Group study |
| Q91980983 | Antitumor Activity of 1,18-Octadecanedioic Acid-Paclitaxel Complexed with Human Serum Albumin |
| Q33180943 | Development of multidrug-resistance convertors: sense or nonsense? |
| Q74296310 | Differences in docetaxel and paclitaxel activity in resistant tumor cells which express MRP: need of comparative clinical trials in resistant patients |
| Q43791704 | Docetaxel as rescue medication in anthracycline- and ifosfamide-resistant locally advanced or metastatic soft tissue sarcoma: results of a phase II trial |
| Q41986750 | Docetaxel inhibits SMMC-7721 human hepatocellular carcinoma cells growth and induces apoptosis |
| Q33996166 | Docetaxel: a review of its use in non-small cell lung cancer |
| Q33897239 | Docetaxel: an update of its use in advanced breast cancer |
| Q36084123 | In vivo cell-cycle profiling in xenograft tumors by quantitative intravital microscopy |
| Q40396037 | Nontoxic suramin treatments enhance docetaxel activity in chemotherapy-pretreated non-small cell lung xenograft tumors |
| Q34698624 | Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine |
| Q35775850 | Poly(2-oxazoline) based micelles with high capacity for 3rd generation taxoids: preparation, in vitro and in vivo evaluation |
| Q44558863 | Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel |
| Q34597483 | Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo |
| Q34224849 | Taxanes in lung cancer: a review with focus on the European experience |
| Q39605246 | Ultra-small lipid-polymer hybrid nanoparticles for tumor-penetrating drug delivery |
| Q77490065 | [Current developments in use of docetaxel (taxotere) in gynecologic oncology] |
Search more.